BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 2)
Image/Profounda

Balamuthia: Profounda receives Orphan Drug Designation to use miltefosine for treatment

By

Orlando-based specialty pharmaceutical company, Profounda announced it has received the US Food and Drug Administration’s Orphan Drug Designation for the use of Impavido (miltefosine) to treat Granulomatous...

A study by University of Michigan Kellogg Eye Center shows 60 percent of pink eye patients get antibiotic eye drops, but they are seldom necessary. Image/Michigan Medicine/Manifest

Many ‘pink eye’ infections treated unnecessarily with antibiotics: Study

By

A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment. About 60 percent of patients nationwide are prescribed antibiotic eye drops, even though antibiotics...

Staphylococcus aureus /CDC

FDA approves new fluoroquinolone antibiotic, Baxdela

By

Melinta Therapeutics announced Monday that the U.S. Food and Drug Administration (FDA) has approved Baxdela™ (delafloxacin), indicated in adults for the treatment of acute bacterial skin and skin structure...

Pseudouridimycin and Rifampin Image/David Degen and Richard H. Ebright (Rutgers University)

Pseudouridimycin: A new antibiotic effective against drug-resistant bacteria

By

Scientists from Rutgers University-New Brunswick, the biotechnology company NAICONS Srl., and elsewhere have discovered a new antibiotic effective against drug-resistant bacteria: pseudouridimycin. The...

Actinomycetes is in a plate Image/DTU/DTU Biosustain

Superbugs: Some get their resistance genes in a complex process involving bacterial ‘sex’

By

To win the war against antibiotic resistant super bugs, scientists seek to find the origin of resistance genes. Further, they try to identify how the genes are introduced to disease-causing bacteria –...

Mature Plasmodium vivax schizont/CDC

Malaria drug, tafenoquine, show positive results from two phase III studies

By

GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced positive results from two phase III studies of tafenoquine, an investigational 8-aminoquinoline, for the prevention of relapse...

Endo Pharmaceuticals asked to remove Opana ER from the market

By

On Thursday, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful...

Methicillin-resistant Staphylococcus aureus (MRSA) Image/NIAID

Phase 3 antibiotic, omadacycline, highly active against common bacterial pathogens in ABSSSI, RTI and UTI

By

New data presented today at ASM Microbe 2017 showed that Paratek Pharmaceuticals, Inc.’s Phase 3 antibiotic omadacycline is highly active against common bacterial pathogens in acute skin and skin structure...

Staphylococcus aureus /CDC

MRSA, C. diff and other healthcare-associated infections

By

According to the Centers for Disease Control and Prevention (CDC), on any given day, about one in 25 hospital patients has at least one healthcare-associated infection (HAI). Clearly, HAIs are a huge problem...

Scientists at Yale University are working on a chemical process that may lead to the creation of a new class of antibiotics. Image/Michael S. Helfenbein

Antibiotics: New chemical process developed that may lead to new class

By

Yale University scientists have developed a novel chemical process that may lead to the creation of a new class of antibiotics. The discovery comes at a time when more types of bacteria are becoming resistant...